Showing results (1261-1270 of 3,096) with videos related to
Sort By:
Pageof 310
Expert Review of Anticancer Therapy|September 16, 2022
Pembrolizumab as a single agent for patients with MSI-H advanced endometrial carcinomaMargherita Turinetto, Valentina Lombardo, Carmela Pisano, et al.Expert Review of Anticancer Therapy|October 20, 2022
Nivolumab with or without chemotherapy for metastatic gastroesophageal cancers and future perspectivesMatheus Sewastjanow-Silva, Kohei Yamashita, Ernesto Rosa Vicentini, et al.Expert Review of Anticancer Therapy|November 29, 2023
Novel therapies for metastatic prostate cancerAlbert Jang, Sree M Lanka, Hui Ting Ruan, et al.Expert Review of Anticancer Therapy|January 22, 2024
Safety and efficacy of Rucaparib in the treatment of ovarian cancer and patients with BRCA mutation: a systematic review and meta-analysis of phase III randomized clinical trialsMus'ab Theeb Mustafa, Aws Khalid Abushanab, Mahmoud Taysir Mousa, et al.Expert Review of Anticancer Therapy|January 4, 2024
Comparison of poly (ADP-ribose) polymerase inhibitors (PARPis) as maintenance therapy for newly-diagnosed and platinum-sensitive recurrent ovarian cancer with BRCA mutational status: a systematic review and network meta-analysisShulin Zhou, Yi Jiang, Chengyan Luo, et al.Expert Review of Anticancer Therapy|March 12, 2024
Drug-drug interaction potential among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) treated with novel androgen receptor inhibitorsSreevalsa Appukkuttan, Gilbert Ko, Chunmay Fu, et al.Expert Review of Anticancer Therapy|November 11, 2023
Efficacy and toxicity of drugs targeting KRASG12C mutation in non-small cell lung cancer: a meta-analysisWei Luo, Jing Zhu, Wenxue Zhang, et al.Expert Review of Anticancer Therapy|May 24, 2024
Current management of familial adenomatous polyposisSara Lauricella, Emanuele Rausa, Ilaria Pellegrini, et al.Expert Review of Anticancer Therapy|June 10, 2024
Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer?Lorenzo Foffano, Riccardo Vida, Alberto Piacentini, et al.Expert Review of Anticancer Therapy|May 27, 2024
Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myelomaPaola Tacchetti, Marco Talarico, Simona Barbato, et al.Pageof 310